Form 4: Evolv Director Sells Shares After Option Exercise

Evolv Technologies Director Michael Ellenbogen exercised stock options and subsequently sold 80,745 Class A Common Stock shares for approximately $5.80 per share, as part of a pre-arranged 10b5-1 trading plan.

Summary

• Michael Ellenbogen, a Director of Evolv Technologies Holdings, Inc. (EVLV), executed a pre-planned transaction on November 17, 2025.
• Exercised options to acquire 80,745 shares of Class A Common Stock at an exercise price of $0.24 per share.
• Immediately sold the same 80,745 shares of Class A Common Stock at a weighted average price of $5.80 per share.
• The sales were conducted under a Rule 10b5-1 trading plan established on June 12, 2025.
• Following these transactions, Michael Ellenbogen directly beneficially owns 2,083,961 shares of Class A Common Stock and indirectly owns 151,135 shares through the Family Horizon Trust.
• He also retains 1,462,229 unexercised stock options.

Sentiment

Score: 5

Explanation: The transaction represents a routine, pre-planned insider sale following an option exercise, which is generally neutral in sentiment.

Positives

• Director Michael Ellenbogen realized a gain by exercising options at $0.24 and selling shares at a weighted average price of $5.80.
• The transaction was executed under a pre-arranged Rule 10b5-1 trading plan, indicating a structured and non-discretionary sale.

Negatives

• An insider sale, even if pre-planned, can sometimes be perceived negatively by the market, though the amount is relatively small compared to total holdings.

Related Party Transactions

• The transaction involves a director of the company, Michael Ellenbogen, making it a related party transaction.

Stakeholder Impact

• Shareholders: The sale by a director, even if pre-planned, could be interpreted in various ways, but given it's a 10b5-1 plan, it is less likely to signal a negative outlook on the company. It represents a director monetizing vested equity.

Key Dates

Recommendation

This Form 4 filing details a pre-planned insider transaction where a director exercised options and immediately sold the acquired shares. Such transactions, especially when executed under a 10b5-1 plan, are typically for personal financial planning and do not necessarily reflect a change in the director's outlook on the company's future performance. Without additional information from other filings (e.g., earnings reports, strategic updates), this specific transaction alone does not provide a strong basis for a "buy" or "sell" recommendation, thus a "hold" stance is appropriate.

Keywords

Evolv Technologies Holdings, Inc., EVLV, Insider Trading, Form 4, Stock Option Exercise, Share Sale, Michael Ellenbogen, 10b5-1 Plan, Director Transaction